Clinical Report: ESWT versus HILT in Knee Osteoarthritis Treatment

Overview

This single-blind randomized clinical trial compared extracorporeal shock wave therapy (ESWT) and high-intensity laser therapy (HILT) in patients with stage 2–3 knee osteoarthritis. Both treatments demonstrated effectiveness in reducing pain and improving function, with distinct biological mechanisms underlying their therapeutic effects.

Background

Knee osteoarthritis (OA) is a degenerative joint disease causing pain, stiffness, and disability, commonly affecting older adults. Treatment aims to reduce pain and improve function, with no curative options currently available. Non-pharmacological therapies such as ESWT and HILT have gained attention due to their non-invasive nature and potential to promote tissue regeneration and reduce inflammation. However, direct comparative studies between these modalities are limited, necessitating research to clarify their relative clinical benefits.

Data Highlights

Sixty patients with stage 2–3 knee OA were randomized equally into two groups: HILT (n=30) and ESWT (n=30). Assessments were conducted at baseline, 2 weeks, and 6 weeks post-treatment using Visual Analog Scale (VAS) for pain, WOMAC, and Lequesne indices for function. Both groups showed clinical improvement over time.

Key Findings

• Both ESWT and HILT significantly reduced pain scores measured by VAS at 2 and 6 weeks post-treatment.
• Functional status, assessed by WOMAC and Lequesne indices, improved in both treatment groups.
• ESWT promotes tissue regeneration and neovascularization through mechanotransduction and growth factor expression.
• HILT enhances local blood circulation and exerts analgesic and anti-inflammatory effects via biostimulation.
• The study fills a gap by directly comparing ESWT and HILT, highlighting their distinct mechanisms and clinical outcomes.

Clinical Implications

Clinicians may consider both ESWT and HILT as effective non-invasive options for managing pain and improving function in patients with moderate knee osteoarthritis. Selection between these modalities can be guided by patient-specific factors and availability, recognizing their differing biological actions. Incorporating these therapies alongside exercise may optimize symptomatic relief and functional gains.

Conclusion

This trial demonstrates that both ESWT and HILT are beneficial for treating knee osteoarthritis, with each modality offering unique therapeutic mechanisms. Further research could refine treatment protocols to maximize patient outcomes.

References

1. Wang et al. 2012 -- Shock waves stimulate growth factors for tissue repair
2. American College of Rheumatology Criteria 1995 -- Classification of Osteoarthritis
3. Kellgren and Lawrence 1957 -- Radiological assessment of osteoarthritis